Angiotensin-converting Enzyme Inhibitors-induced Angioedema

Anca Chiriac; Piotr Brzezinski; Mircea Betiu; Liliana Foia

doi:10.2478/jce-2018-0004

.blurhash-client-img { display: none !important; }

Angiotensin-converting Enzyme Inhibitors-induced Angioedema

Journal of Cardiovascular Emergencies

Volume 4 (2018): Issue 1 (March 2018)

By: Anca Chiriac, Piotr Brzezinski, Mircea Betiu and Liliana Foia

Open Access

|Apr 2018

Abstract

Angiotensin-converting enzyme inhibitors (ACEI) are widely used drugs nowadays in treating patients diagnosed with cardiovascular disorders. We present two consecutive cases of acquired angioedema caused by the administration of enalapril and lisinopril in patients with indication for ACE-inhibitors therapy. Rigorous follow-up of side effects of ACEI is required, due to these possible life-threatening adverse reactions.

References

1. Korzeniowska K, Cielewiczi A, Pawlaczyk M, Motowidlo K, Andrys-Wawrzyniak I, Jablecka A. Angioedema after angiotensin-converting enzyme inhibitors. Acta Pol Pharm. 2017;74:983-986.
Search in Google Scholar Back to article
2. Cicardi M, Agostoni A. Hereditary angioedema. N Engl J Med. 1996;334:1666-1667. doi:10.1056/NEJM199606203342510.10.1056/NEJM1996062033425108628365
Open DOI Search in Google Scholar Back to article
3. Sánchez-Borges M, González-Aveledo L. Angiotensin-Converting Enzyme Inhibitors and Angioedema. Allergy Asthma Immunol Res. 2010;2:195-198. doi: 10.4168/aair.2010.2.3.195.10.4168/aair.2010.2.3.195289205220592919
Open DOI Search in Google Scholar Back to article
4. Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies. J Emerg Med. 2013;45:789-796. doi: 10.1016/j.jemermed.2013.03.045.10.1016/j.jemermed.2013.03.04523992848
Open DOI Search in Google Scholar Back to article
5. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007;62:842-56. doi: 10.1111/j.1398-9995.2007.01427.x.10.1111/j.1398-9995.2007.01427.x17620062
Open DOI Search in Google Scholar Back to article
6. Banerji A. Current treatment of hereditary angioedema: An update on clinical studies. Allergy Asthma Proc. 2010;31:398-406. doi: 10.2500/aap.2010.31.3387.10.2500/aap.2010.31.338720929607
Open DOI Search in Google Scholar Back to article
7. Baram M, Kommuri A, Sellers SA, Cohn JR. ACE inhibitorinduced angioedema. J Allergy Clin Immunol Pract. 2013;1:442-445. doi: 10.1016/j.jaip.2013.07.005.10.1016/j.jaip.2013.07.00524565614
Open DOI Search in Google Scholar Back to article
8. Mlynarek A, Hagr A, Kost K. Angiotensin-converting enzyme inhibitor-induced unilateral tongue angioedema. Otolaryngol Head Neck Surg. 2003;129:593-595. doi: 10.1016/S0194-59980300724-1.10.1016/S0194-59980300724-1
Search in Google Scholar Back to article
9. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51:1624-1630. doi: 10.1161/HYPERTENSIONAHA.108.110270.10.1161/HYPERTENSIONAHA.108.11027018413488
Open DOI Search in Google Scholar Back to article
10. Cupido C, Rayner B. Life-threatening angio-oedema and death associated with the ACE inhibitor enalapril. S Afr Med J. 2007;97:244-245.
Search in Google Scholar Back to article
11. Chin HL, Buchan DA. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor. Ann Intern Med. 1990;112:312-313.10.7326/0003-4819-112-4-312_22297216
Search in Google Scholar Back to article
12. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165:1637-1642. doi: 10.1001/archinte.165.14.1637.10.1001/archinte.165.14.163716043683
Open DOI Search in Google Scholar Back to article
13. Morimoto T, Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensinconverting enzyme inhibitors. J Eval Clin Pract. 2004;10:499-509. doi: 10.1111/j.1365-2753.2003.00484.x.10.1111/j.1365-2753.2003.00484.x15482412
Search in Google Scholar Back to article
14. Abbosh J, Anderson JA, Levine AB, Kupin WL. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients. Ann Allergy Asthma Immunol. 1999;82:473-476. doi: 10.1016/S1081-1206(10)62723-8.10.1016/S1081-1206(10)62723-8
Open DOI Search in Google Scholar Back to article
15. Weber MA, Messerli FH. Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk. Hypertension. 2008;51:1465-1467. doi: 10.1161/HYPERTENSIONAHA.108.111393.10.1161/HYPERTENSIONAHA.108.11139318413486
Open DOI Search in Google Scholar Back to article
16. Riedl M. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clin Ther. 2012;34:623-630. doi: 10.1016/j.clinthera.2012.02.003.10.1016/j.clinthera.2012.02.00322386830
Open DOI Search in Google Scholar Back to article
17. Farkas H, Martinez-Saguer I, Bork K, et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy. 2017;72:300-313. doi: 10.1111/all.13001.10.1111/all.13001524862227503784
Open DOI Search in Google Scholar Back to article
18. Betschel S, Badiou J, Binkley K, et al. Canadian hereditary angioedema guideline. Allergy Asthma Clin Immunol. 2014;10:50. doi: 10.1186/1710-1492-10-50.10.1186/1710-1492-10-50421062525352908
Open DOI Search in Google Scholar Back to article
19. Bork K. An evidence based therapeutic approach to hereditary and acquired angioedema. Curr Opin Allergy Clin Immunol. 2014;14:354-362. doi: 10.1097/ACI.0000000000000082.10.1097/ACI.000000000000008224983294
Open DOI Search in Google Scholar Back to article
20. Bernstein JA, Moellman JJ. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States. Postgrad Med. 2012;124:91-100. doi: 10.3810/pgm.2012.05.2552.10.3810/pgm.2012.05.255222691903
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/jce-2018-0004 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X

Journal RSS Feed

Language: English

Page range: 47 - 50

Submitted on: Feb 12, 2018

Accepted on: Mar 12, 2018

Published on: Apr 25, 2018

Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

angiotensin-converting enzyme inhibitors,

Related subjects:

Emergency medicine and intensive-care medicine,

Radiology

© 2018 Anca Chiriac, Piotr Brzezinski, Mircea Betiu, Liliana Foia, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 4 (2018): Issue 1 (March 2018)